Intra-medullary antibiotics perfusion (iMAP) for the control of fracture-related infection early after osteosynthesis.
Akihiro MaruoTakahiro OdaHidetoshi MiyaHirotsugu MuratsuTomoaki FukuiKeisuke OeRyosuke KurodaTakahiro NiikuraPublished in: Journal of orthopaedic surgery (Hong Kong) (2021)
iMAP is a novel local drug delivery system allowing high concentrations of antibiotics to be administered without complications and is useful in the treatment of FRI.